The circulating renin-angiotensin system and mortality among patients hospitalized for COVID-19: a mechanistic substudy of the ACTIV-4 Host Tissue trials
Christopher L. Schaich(Wake Forest University), Matthew S. Shotwell(Vanderbilt University Medical Center), Aaron Barksdale(University of Nebraska Medical Center), Adit A. Ginde(University of Colorado Anschutz Medical Campus), Wesley H. Self(Vanderbilt University Medical Center), Kevin W. Gibbs(Wake Forest University), Michael A. Puskarich(University of Minnesota), Todd W. Rice(Vanderbilt University), Meghan M. Joly(UL Research Institutes), Sean P. Collins(Wayne State University), Michael J. Lanspa(Intermountain Healthcare), Michelle Harkins(University of New Mexico), Mark C. Chappell(Wake Forest University), Joseph E. Levitt(Stanford University), Ivor S. Douglas(Westchester Medical Center), Peter Chen(Cedars-Sinai Medical Center), D. Clark Files(Wake Forest University), Kristin Hudock(Cincinnati Children's Hospital Medical Center)
American Journal of Physiology-Lung Cellular and Molecular Physiology
January 30, 2025
Cited by 4
Related Papers
Surviving Sepsis Campaign
|Critical Care Medicine|2013|9.7k
Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock, 2012
|Intensive Care Medicine|2013|7.3k
A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus–induced lung injury
|Nature Medicine|2005|3.7k
Community-Acquired Pneumonia Requiring Hospitalization among U.S. Adults
|New England Journal of Medicine|2015|3.4k